Szemészet, 1992 (129. évfolyam, 1-4. szám)
1992-03-01 / 1. szám
Szemészet, 129 (1992) 19 J.A.: Human ciliary process adrenergic receptor. Pharmacologic characterization. Invest. Ophthalmol. Vis. Sei. 21, 798 (1981) Allen, R.C. et al.: A double-masked comparison of betaxolol vs timolol in the treatment of open-angle glaucoma. Am.J.Ophthalmol. 101, 535 (1986). 19. Nathanson, J.A.: Adrenergic regulation of IOP. Identification of-adrenergic stimulated adenylate cyclase in ciliary process epithelium. Proc. Natl. Acad. Sei. USA 77, 7420 (1980) cit.: Allen, R.C. et al.: A doublemasked comparison of betaxolol vs timolol in the treatment of openangle glaucoma. Am. J. Ophthalmol. 101, 535 (1986). 20. Olson, R.J., Bronberg, B.B., Zimmerman, T.J.: Apneic spells associated with timolol therapy in a neonate. Am.J.Ophthalmol. 88, 120 (1979). 21. Phillips, С.1., Howitt, G., Rowlands, D.J. : Propranolol as ocular hypotensive agent. Br. J. Ophthalmol. 51, 222 (1967). 22. Radius, R.L., Diamond, G.R., Pollack, I.P. and Langham, M.E.: Timolol. A new drug for management of chronic simple glaucoma. Arch-Ophthalmol. 96, 1003 (1978). 23. Rahi, A.H., Chapman, C.M., Gamer, A. etal.: Pathology of practolol-induced ocular toxicity. Br. J. Ophthalmol. 60, 312, (1976). 24. Reiss, G., and Brubaker, R.K. The mechanism of betaxolol, a new ocular hypotensive agent. Ophthalmology 90, 1369, (1983). 25. Schoene, R.B., Abuan, T., Ward, R.L., Beasley, C.H.: Effects of topical betaxolol, timolol, and placebo on pulmonary function in asthmatic bronchitis. Am. J. Ophthalmol. 97, 86, (1984). 26. Schoene, R.B., Martin, T.R., Charan, N.B., French, C.L.: Timolol-induced bronchospasm in asthmatic bronchitis. JAMA 245, 1460 (1981). 27. Sharaf, E., Hamun, E.A., Ishae, Z., et al.: The effect of some beta-adrenergic blockers on human intraocular pressure. Exp. Eye Res. 19, 223 (1974) cit.: Berrospi, A.R., Leibowitz, H.M.: Betaxolol. A new beta-adrenergic blocking agent for treatment of glaucoma. Arch. Ophthalmol. 100, 943 (1982). 28. Van Burkirk, E. M.: Corneal anesthesia after timolol maleate therapy. Am. J. Ophthalmol. 88, 739, (1979). 29. Van Burkirk, E.M. etal.: Betaxolol in patients with glaucoma and asthma. Am. J. Ophthalmol. 101, 531 (1986). 30. Wettrell,K., Pandolfi, M.: Effect of oral administration of various beta-blocking agents on the intraocular pressure in healthy volunteers. Exp. Eye Res. 21, 451 (1975) cit.: Berrospi, A.R., Leibowitz, H.M.: Betaxolol. A new beta-adrenergic blocking agent for treatment of glaucoma. Arch. Ophthalmol. 100, 943 (1982). 31. Wright, P.: Untoward effects associated with practolol administration: oculomucocutaneous syndrome. Br. Med. J. 1, 595 (1975). 32. Zimmerman, T.J., Harbin, Dett, M.: Timolol and facility of outflow. Invest. Ophthalmol. Vis. Sei. 16, 623 (1977) cit.: Allen, R.C. et al.: A double-masked comparison of betaxolol vs timolol in the treatment of open-angle glaucoma. Am. J. Ophthalmol. 101, 535 (1986). 33. Zimmerman, T.J., Kaufman, H. E.: A beta-adrenergic blocking agent for the treatment of glaucoma. Arch. Ophthalmol. 95, 601, (1977). Cím: Dr. Jaross Nándor DOTE Szemészeti Klinika 4012 Pf. 29.
